PYRAZINAMIDE/PYRAZINOIC ACID RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS: RECENT FINDINGS AND IMPLICATIONS FOR IMPROVING THE TREATMENT OF TUBERCULOSIS
Abstract. Pyrazinamide (PZA) is unique in that it is a component of the first line therapy for drug sensitive tuberculosis and in most current and experimental treatments also for multi drug resistant tuberculosis. Furthermore, PZA has been shown to help to ensure lasting cure and prevent relapse in...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | RU |
| Publié: |
Sankt-Peterburg : NIIÈM imeni Pastera
2018
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/f1887f2eca534864a7aa89f5d09b7057 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|